Cynata Therapeutics Limited CYP.AX
CYP.AX
Cynata Therapeutics Limited PTX.AX
Prescient Therapeutics Limited NSB.AX
NeuroScientific Biopharmaceuticals Limited PIQ.AX
Proteomics International Laboratories Limited AGN.AX
Argenica Therapeutics Limited GSS.AX
Genetic Signatures Limited ADO.AX
AnteoTech Limited ATX.AX
Amplia Therapeutics Limited EYE.AX
Nova Eye Medical Limited NOX.AX
Noxopharm Limited
Cynata Therapeutics Limited PTX.AX
Prescient Therapeutics Limited NSB.AX
NeuroScientific Biopharmaceuticals Limited PIQ.AX
Proteomics International Laboratories Limited AGN.AX
Argenica Therapeutics Limited GSS.AX
Genetic Signatures Limited ADO.AX
AnteoTech Limited ATX.AX
Amplia Therapeutics Limited EYE.AX
Nova Eye Medical Limited NOX.AX
Noxopharm Limited
Performance
| Periode | CYP.AX | PTX.AX | NSB.AX | PIQ.AX | AGN.AX | GSS.AX | ADO.AX | ATX.AX | EYE.AX | NOX.AX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 35.90 % | -4.44 % | 193.48 % | -21.35 % | -60.29 % | -39.02 % | 155.56 % | 178.85 % | 57.14 % | 9.41 % |
| YTD | 10.42 % | -15.69 % | 309.09 % | -55.41 % | -57.48 % | -62.12 % | 21.05 % | 55.91 % | -5.71 % | 2.20 % |
| 1Y | 15.22 % | -2.27 % | 255.26 % | -55.13 % | -65.38 % | -62.12 % | -10.80 % | 0.00 % | -10.81 % | -19.13 % |
| 3Y | -20.90 % | -76.11 % | 48.35 % | -63.73 % | -40.66 % | -68.01 % | -57.05 % | 50.70 % | -33.55 % | -49.73 % |
| 5Y | -67.98 % | -32.81 % | -58.46 % | -40.17 % | 3.85 % | -86.34 % | -82.16 % | -44.16 % | -47.05 % | -79.56 % |
| 10Y | -44.63 % | -25.16 % | -40.00 % | 12.90 % | 3.85 % | -43.75 % | -74.19 % | -91.10 % | -66.11 % | -43.08 % |
| From the beginning | -89.77 % | -99.88 % | -40.00 % | 75.00 % | 3.85 % | -47.23 % | -99.07 % | -91.76 % | -98.37 % | -43.08 % |